Crossref
The Expression and Clinical Significance of Serum Long Noncoding RNA TTTY15 in Patients With Multiple Myeloma
Clinical Laboratory · 2026 · 72 (06/2026)
DOI: 10.7754/clin.lab.2025.250727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Yuan Zhang und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Multiple Myeloma, RNA, Long Noncoding, Biomarkers, Tumor.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Multiple MyelomaRNA, Long NoncodingBiomarkers, TumorHumansMaleMiddle AgedAgedCase-Control Studiesbeta 2-MicroglobulinGene Expression Regulation, NeoplasticFemale
Substanzen
RNA, Long NoncodingBiomarkers, Tumorbeta 2-Microglobulin
Zitieren
APA
Zhang, Y., Chen, J., Sun, X., Gu, Q., Chen, Y., & Xie, J. (2026). The Expression and Clinical Significance of Serum Long Noncoding RNA TTTY15 in Patients With Multiple Myeloma. Clinical Laboratory, 72(06/2026). https://doi.org/10.7754/clin.lab.2025.250727
Vancouver
Zhang Y, Chen J, Sun X, Gu Q, Chen Y, Xie J. The Expression and Clinical Significance of Serum Long Noncoding RNA TTTY15 in Patients With Multiple Myeloma. Clinical Laboratory. 2026;72(06/2026). doi:10.7754/clin.lab.2025.250727
BibTeX
@article{Zhang2026,
author = {Zhang, Yuan and Chen, Jun and Sun, Xiaoye and Gu, Qunyong and Chen, Yi and Xie, Jinyu},
title = {The Expression and Clinical Significance of Serum Long Noncoding RNA TTTY15 in Patients With Multiple Myeloma},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {06/2026},
doi = {10.7754/clin.lab.2025.250727}
}
EUVIMED